Founded by Timothy Glennon, ISG brings senior executive leadership built on 30 years across pharma, biotech, medical devices, and diagnostics — anchored by a decade-plus in EVP-level roles at Evofem Biosciences and Veru Inc., and senior commercial leadership at Teva Pharmaceuticals and Bayer Healthcare.
Across that career, Tim has built commercial organizations from inception, led 15+ product launches generating over $2B in cumulative revenue, managed P&Ls exceeding $100M, and served as a primary interface between commercial execution and the investor community — translating business performance into compelling capital narratives.
ISG is built on a simple premise: life sciences innovators making their most consequential decisions deserve senior commercial leadership, structured to fit the moment — whether that’s a fractional executive role embedded in the company, or a defined-scope engagement focused on a single inflection point.
Most life sciences advisors do one thing well — strategic frameworks or hands-on execution. ISG delivers both. We craft long-range corporate strategy, lead capital raises, close licensing deals, and build the commercial teams that take products to market — often inside the same engagement.
That dual capability matters because life sciences inflection points don’t respect functional boundaries. A capital raise depends on a credible commercial narrative. A launch depends on the team you’ve built to execute it. A licensing deal depends on the strategic logic of the portfolio it joins. ISG works at the intersection of all three.
We engage as a true partner — embedded in board discussions, investor conversations, and operational reviews. The result is strategic clarity that translates directly into commercial momentum.
Illuminations Strategic Group brings a unique ability to translate complex business challenges into clear strategic direction. Their guidance helped our leadership team focus on the opportunities that truly drive growth.
ISG structures engagements around the moment, not a service menu. Whether you need embedded leadership for a multi-quarter build or a defined-scope project for a single inflection point, the standard is the same: senior commercial expertise from someone who has done it before.
Embedded executive leadership for life sciences companies that need senior commercial firepower without a full-time hire. Engagements include Fractional Chief Commercial Officer, Fractional Chief Business Officer, and Fractional Chief Marketing Officer roles — typically structured as multi-quarter commitments with direct accountability to the board.
Defined-scope engagements built around a specific inflection point: capital raise preparation, in-licensing diligence, launch readiness, partner identification, market access strategy, or commercial organization design. Each engagement is structured around a primary scope, with additional workstreams scoped and authorized as the work evolves.
Senior support for seed through Series C raises, convertible note bridges, board and investor communications, and the capital narrative that connects commercial strategy to funding milestones. Active experience leading capital raises and presenting to boards and investor stakeholders.
Strategy and execution support for commercial launches — from pre-launch infrastructure build through commercial team scaling, market access strategy, and post-launch optimization. Built on 15+ product launches across nine therapeutic areas.
Life sciences innovation creates value when it reaches the patients who need it. The decisions that determine whether a science-driven company gets there — capital, commercial strategy, organizational design, partnerships — too often get made without the senior commercial experience required to make them well.
ISG exists to close that gap. We bring senior commercial leadership to the inflection points that determine whether innovation translates into impact, building organizations that create value for patients, investors, and partners alike.
To bring senior commercial leadership to life sciences innovators at the moments that determine their future.
.svg)
A life sciences industry where every science-driven company has access to the commercial leadership it needs, when it needs it.
Every engagement starts with the same diagnostic: what is the inflection point, what does success look like, and what kind of leadership presence does the moment require? From there, we structure the work — fractional or project-based — and engage as a true commercial partner from kickoff through outcome.
We define the inflection point, success criteria, and the leadership structure that fits the moment — fractional, project-based, or hybrid.
We scope the primary engagement and identify additional workstreams that may be authorized as the work evolves.
We deliver the substantive work: commercial strategy, capital formation, BD/in-licensing, launch planning, organizational design for whatever the moment demands.
For most engagements, we present directly to boards of directors and investor stakeholders, providing strategy updates, financial performance reporting, and pipeline development briefings.
We close out engagements with clear deliverables and, where appropriate, structured transition to internal leadership.
ISG works at the senior commercial layer of life sciences — with the founders, executives, boards, and investors who shape strategic direction.
See how senior commercial leadership has helped life sciences companies navigate capital raises, in-licensing decisions, commercial launches, and the organizational builds required to execute on all three.
.png)
15+ launches supported
$2B+ potential commercial value unlocked
12 months from strategy to launch readiness value unlocked
15+ launches supported
$2B+ potential commercial value unlocked
12 months from strategy to launch readiness value unlocked
15+ launches supported
$2B+ potential commercial value unlocked
12 months from strategy to launch readiness value unlocked
15+ launches supported
$2B+ potential commercial value unlocked
12 months from strategy to launch readiness value unlocked
Let’s talk about what you’re facing — and how the right engagement structure can move your company forward.
.svg)
.svg)
